WO2026046268 - MINIPROTEIN BINDING TO PD-L1 AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/046268
Publication Date
05.03.2026
International Application No.
PCT/CN2025/117430
International Filing Date
28.08.2025
Title **
[English]
MINIPROTEIN BINDING TO PD-L1 AND USE THEREOF
[French]
MINIPROTÉINE SE LIANT À PD-L1 ET SON UTILISATION
[Chinese]
一种结合PD-L1的微蛋白及其应用
Applicants **
SHANGHAI AILUX BIOTECHNOLOGY CO., LTD.
Inventors
LIANG, Chuheng
LONG, Yunfei
ZHAO, Mingjun
CHEN, Xi
LI, Jie
XIA, Chunqiu
ZHANG, Hongning
Priority Data
202411206504.9
29.08.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1760 | |
| EPO | Filing, Examination, Granting | 11790 | |
| Japan | Filing, Examination, Granting | 2154 | |
| South Korea | Filing, Examination, Granting | 2132 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,576
Contact Us
Abstract[English]
The present invention belongs to the field of biomedicine. Provided are a miniprotein binding to PD-L1 and the use thereof. Further provided are a nucleic acid molecule encoding the miniprotein, a vector, a host cell, and a conjugate, and the use thereof for treating tumors.[French]
La présente invention se rapporte au domaine de la biomédecine. L'invention concerne une miniprotéine se liant à PD-L1 et son utilisation. L'invention concerne en outre une molécule d'acide nucléique codant pour la miniprotéine, un vecteur, une cellule hôte et un conjugué, ainsi que leur utilisation pour le traitement de tumeurs.[Chinese]
提供了一种结合PD-L1的微蛋白及其应用，属于生物医药领域。还提供了编码该微蛋白的核酸分子、载体、宿主细胞及缀合物，及其治疗肿瘤的应用。